Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) Shares Outstanding (Weighted Average) (2024 - 2025)

RenovoRx (RNXT) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $35.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 58.65% to $35.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.3 million through Dec 2025, up 58.65% year-over-year, with the annual reading at $35.3 million for FY2025, 58.65% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $35.3 million in Q4 2025 for RenovoRx, up from $34.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $36.6 million in Q2 2025 to a low of $14.9 million in Q1 2024.